A plethora of studies have documented that gene expression profiling using DNA microarrays for various types of hematological malignancies provides novel information, which may have diagnostic and ...
The ability of microarrays to measure thousands of RNA transcripts at one time allows for the characterization of cells and tissues in greater depth than was previously possible, but has not yet led ...
The Microarray Innovations in Leukemia study assessed the clinical utility of gene expression profiling as a single test to subtype leukemias into conventional categories of myeloid and lymphoid ...
Statistical and Biological Review of Transcriptome Data Made Possible by Interactive Report Although bench scientists understand the value of using gene-expression microarray technology, the full ...
Current staging methods are inadequate for predicting the outcome of treatment of non–small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely associated with survival of ...
The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...
A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...